Sterne Agee Starts Actavis (ACT) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
National Alliance Securities Starts Actavis (ACT) at Buy
April 17, 2014 9:20 AM EDTNational Alliance Securities initiated coverage on Actavis (NYSE: ACT) with a Buy rating and a price target of $246.00.
Analyst Corey Davis said, "1) ACT is now off 16% from its all-time high of $227 in Feb.; 2) we model a healthy 22% EPS CAGR 13-18; 3) it carries... More
